NeoGenomics
NEO
#5070
Rank
A$2.67 B
Marketcap
A$20.53
Share price
3.20%
Change (1 day)
86.81%
Change (1 year)

Operating Margin for NeoGenomics (NEO)

Operating Margin as of June 2026 (TTM): -15.16%

According to NeoGenomics 's latest financial reports and stock price the company's current Operating Margin is -15.16%. At the end of 2025 the company had an Operating Margin of -15.16%.

Operating Margin history for NeoGenomics from 2001 to 2026

Operating Margin at the end of each year

Year Operating Margin Change
2025-15.16%24.13%
2024-12.21%-25.58%
2023-16.41%-47.5%
2022-31.26%904.33%
2021-3.11%-1.58%
2020-3.16%-454.72%
20190.89%-35.48%
20181.38%-225.27%
2017-1.10%-67.4%
2016-3.38%-24.78%
2015-4.50%-403.82%
20141.48%-54.97%
20133.29%2927.75%
20120.11%-104.01%
2011-2.71%-68.6%
2010-8.62%47.01%
2009-5.86%32.77%
2008-4.42%-83.82%
2007-27.30%-1362.95%
20062.16%-105.09%
2005-42.45%-67.53%
2004-130.73%-2.16%
2003-133.61%-78.6%
2002-624.31%-99.92%
2001-807,796.60%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
Quest Diagnostics
DGX
12.20%-180.47%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
7.93%-152.31%๐Ÿ‡บ๐Ÿ‡ธ USA
RadNet
RDNT
1.56%-110.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Psychemedics
PMD
-9.73%-35.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
-28.53% 88.19%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.